Amgen Says Experimental Obesity Drug Has Promising Durability ...Middle East

Amgen's experimental obesity drug demonstrated promising durability trends in an early trial, paving the way for a larger mid-stage study early next year, company officials said ahead of a data presentation on Saturday. Reuters Health Information

Hence then, the article about amgen says experimental obesity drug has promising durability was published today ( Monday 05/12/2022 - 05:08 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Amgen Says Experimental Obesity Drug Has Promising Durability )

Also on site :

• Gaza plan phase two: US to discuss Hamas disarmament, Israeli withdrawal
• ‘I hope they show humanity’: Greenlanders fear Trump’s desire for minerals
• Amazon Has 'Super Warm' and ‘Soft' Mini Sheepskin Boots on Sale for $50, and They're 'Worth Every Penny'